TH
GSK icon

Transmarket Holdings’s GSK GSK Stock Holding History

Transmarket Holdings’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.88M Sell
188,473
-33,984
-15% -$1.8M 7.25% 3
2026
Q1 		$12.3M Buy
222,457
+194,641
+700% +$10.5M 6.56% 4
2025
Q4 		$1.36M Buy
+27,816
New +$1.3M 1% 19

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Transmarket Holdings's GSK Position: Q2 2026 in Review

Transmarket Holdings reduced its GSK (GSK) stake by 15% in Q2 2026, selling an estimated $1.8M and leaving 188,473 shares worth $9.88M. The position accounts for 7.25% of the portfolio, ranked #3.

Transmarket Holdings first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $12.3M in Q1 2026. 999 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Transmarket Holdings held 188,473 shares of GSK worth $9.88M as of Q2 2026.
  • Transmarket Holdings sold 33,984 GSK shares in Q2 2026, an estimated $1.8M.
  • GSK made up 7.25% of Transmarket Holdings's portfolio in Q2 2026, its #3 holding.
  • Transmarket Holdings first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • Transmarket Holdings's GSK position peaked at $12.3M in Q1 2026.
  • 999 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Transmarket Holdings's 13F filing for Q2 2026, filed 21 Jul 2026.